← Eichor
Study identifier: NCT03120481 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Controls for Respiratory Diseases

Condition: Chronic Obstructive Pulmonary Disease · Asthma · Idiopathic Pulmonary Fibrosis  ·  Sponsor: Seoul National University Hospital

PhaseN/A
Planned participants1572
Who can joinAll sexes, 19 Years to 90 Years
Healthy volunteersYes

About this study

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

This description comes directly from the study's public registry record.

Talk to the study team

Chang-Hoon Lee, M.D.  ·  82-2-2072-4743  ·  kauri670@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University Healthcare System Gangnam CenterSeoul, Seoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03120481